Boston Scientific CorporationBSXNYSE
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+15.8%
5Y CAGR+12.4%
Year-over-Year Change
Research and development spending
3Y CAGR
+15.8%/yr
vs +4.4%/yr prior
5Y CAGR
+12.4%/yr
Recent acceleration
Acceleration
+11.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $2.05B | +27.1% |
| 2024 | $1.61B | +14.2% |
| 2023 | $1.41B | +6.9% |
| 2022 | $1.32B | +9.9% |
| 2021 | $1.20B | +5.3% |
| 2020 | $1.14B | -2.6% |
| 2019 | $1.17B | +5.5% |
| 2018 | $1.11B | +11.6% |
| 2017 | $997.00M | +8.4% |
| 2016 | $920.00M | - |